Back

Effect of sodium-glucose type 2 cotransporter inhibitors on cardiac structure and function in patients with normal ejection fraction

27 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Strain echocardiography and early detection of disease Tissue Doppler, Speckle Tracking and Strain Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Marcelino Cortes Garcia

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
The assessment of left atrial and left atrial appendage mechanics in patients with different stages of atrial fibrillation
Miss Y. Mao (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Resting strain analysis to identify myocardial ischemia in patients with advanced chronic kidney disease.
Doctor D. Tsartsalis (Sundsvall, SE)
Abstract Slides Video
Presentation thumbnail
A preliminary study on the standard value of left ventricular mechanic dyssynchrony by speckle tracking
Doctor J. Tan (Guiyang, CN)
Abstract Slides Video
Presentation thumbnail
Association of subclinical left ventricular systolic dysfunction detected on 2d echocardiogram global longitudinal strain and in-hospital adverse clinical outcomes in covid 19 patients
Doctor S. Ramos (Quezon, PH)
Abstract Slides Video
Presentation thumbnail
Speckle-tracking global longitudinal strain as a predictor of clinical outcomes in patients with idiopathic inflammatory myopathies
Doctor G. Stronati (Ancona, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Strain echocardiography and early detection of disease

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2 inhibitor therapy on left ventricular longitudinal and circumferential strain in patients with type 2 diabetes mellitus and normal left ventricular ejection fraction.
thumbnail
Congress Presentation
Effects of SGLT-2 inhibitors on myocardial work in patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Impact of SGLT2-inhibitors on cardiac function and structural changes in patients with heart failure and reduced ejection fraction - Results from the REWIN-HFrEF Study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources